E2112 Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

June 30, 2018
https://clinicaltrials.gov/ct2/show/NCT02115282
Cancer - Breast
Principal Investigator: Ding Wang, MD
CANCER, RECURRENT, ADVANCED, METASTATIC, ER POSITIVE, BREAST, BREAST CANCER, ESTROGEN RECEPTOR POSITIVE, PR POSITIVE, PROGESTERONE RECEPTOR POSITIVE, HORMONE POSITIVE, HER2 NEGATIVE, HER 2 NEGATIVE
Accepting Participants